Eric K Rowinsky
CIK 1318886 · Chief Medical Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.79M
Companies
11
Total Filings
82
Lifetime Open-Market Net
-$13.07M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIIB | Director | 25,844 | $200.05 | $5.17M | -$12.52M | 24 | 2026-06-11 |
| VSTM | Director | 54,666 | $4.10 | $224.1K | $7.7K | 12 | 2026-05-26 |
| FBIOP | Director | 68,797 | $20.71 | $1.42M | -$117.1K | 8 | 2024-01-03 |
| NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Director | 341,446 | $0.00 | $34 | $0 | 11 | 2018-02-22 |
| FBIO | Director | 350,000 | $2.77 | $969.5K | $0 | 2 | 2017-01-24 |
| DNIB UNWIND, INC. (BIND) Delisted | Director | — | — | — | $0 | 3 | 2016-06-22 |
| STEMLINE THERAPEUTICS INC (STML) Delisted | Chief Medical Officer | 143,688 | — | — | -$479.5K | 6 | 2015-04-28 |
| Fortress Biotech, Inc. (CNDO) Delisted | Director | 150,000 | — | — | $0 | 4 | 2015-03-16 |
| NAVIDEA BIOPHARMACEUTICALS, INC. (NEOP) Delisted | Director | 15,000 | — | — | $38.2K | 2 | 2011-08-23 |
| Savara Inc (ANX) Delisted | Director | — | — | — | $0 | 4 | 2010-07-01 |
| IMCLONE SYSTEMS INC (IMCL) Delisted | SVP, Chief Medical Officer | 0 | — | — | $0 | 4 | 2008-11-24 |
Recent Filings · Page 5 of 9
82 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-10 | DNIB UNWIND, INC. (BIND) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-28 | STEMLINE THERAPEUTICS INC (STML) Delisted | Sell (S) | −10,824 | -$170.7K | EDGAR |
| 2015-03-30 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +22,000 | $0 | EDGAR |
| 2015-03-23 | BIIB | Mixed | — | -$4.84M | EDGAR |
| 2015-03-20 | BIIB | Mixed | — | -$877.9K | EDGAR |
| 2015-03-18 | BIIB | Mixed | — | -$1.71M | EDGAR |
| 2015-03-16 | Fortress Biotech, Inc. (CNDO) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
| 2015-03-11 | BIIB | Mixed | — | -$1.67M | EDGAR |
| 2015-03-10 | STEMLINE THERAPEUTICS INC (STML) Delisted | Grant (A) | +24,379 | $0 | EDGAR |
| 2015-02-20 | STEMLINE THERAPEUTICS INC (STML) Delisted | Sell (S) | −1,640 | -$22.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.